Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07127445) titled 'Metabolic and Epigenetic Impact of FAAH Inhibitors and OEA' on Aug. 11.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: Nicole Stevens, PhD

Condition: Healthy

Intervention: Dietary Supplement: OEA supplement

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: August 2025

Target Sample Size: 100

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07127445

Disclaimer: Curated by HT Syndication....